iA Global Asset Management Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1969566
Quebec, A8
Position in NBIX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,544,837
+$722,223 QoQ
Shares Held
9,166
+58.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#345
of 768 holders
Holding Since
Dec 2023
6 quarters on record
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026iA Global Asset Management Inc. holds $25,098,205 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
341,622 | $11,574,153 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
303,786 | $5,455,996 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
522,992 | $5,141,011 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
9,166 | $1,544,837 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,551 | $1,382,208 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,544,837 | 9,166 | Shares | Sole | 2026-07-29 | |
| 2025-12-31 | $822,614 | 5,800 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $732,081 | 5,215 | Shares | Sole | 2025-10-30 | |
| 2024-09-30 | $305,563 | 2,652 | Shares | Sole | 2024-11-15 | |
| 2024-03-31 | $194,467 | 1,410 | Shares | Sole | 2025-04-08 | |
| 2023-12-31 | $209,103 | 1,587 | Shares | Sole | 2025-04-08 | |
| No filing history on record for this holder in this stock. | ||||||